Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Victoria Seebalack"'
Autor:
Naveen Anand Seecheran, Salma Rafeeq, Nicole Maharaj, Steven Swarath, Valmiki Seecheran, Rajeev Seecheran, Victoria Seebalack, Cathy-Lee Jagdeo, Rajiv Seemongal-Dass, Abel Yoandri Levya Quert, Stanley Giddings, Anil Ramlackhansingh, Sherry Sandy, Shastri Motilal, Robin Seemongal-Dass
Publikováno v:
Cardiology and Therapy, Vol 12, Iss 3, Pp 499-509 (2023)
Abstract Introduction This study aimed to determine whether there was any correlation between coronary artery disease (CAD) and retinal artery diameter at an academic tertiary medical center in Trinidad and Tobago. Methods This prospective study eval
Externí odkaz:
https://doaj.org/article/5b1cfda269eb45c98a5e2c1b87d27148
Autor:
Naveen Seecheran, Victoria Seebalack, Rajeev Seecheran, Aarti Maharaj, Brent Boodhai, Valmiki Seecheran, Sangeeta Persad, Shastri Motilal, Antonio Tello-Montoliu, David Schneider
Publikováno v:
Cardiology and Therapy, Vol 8, Iss 2, Pp 229-237 (2019)
Abstract Introduction This prospective study aimed to determine whether trimetazidine (TMZ) alters the pharmacodynamic (PD) effects of clopidogrel. Methods Patients with stable coronary artery disease (SCAD) (n = 24) who were actively treated with du
Externí odkaz:
https://doaj.org/article/879323feae0348778fc36191ea82ccf1
Autor:
Shastri Motilal, Naveen Seecheran, Victoria Seebalack, Aarti Maharaj, Valmiki Seecheran, David J. Schneider, Rajeev Seecheran, Brent Boodhai, Sangeeta Persad, Antonio Tello-Montoliu
Publikováno v:
Cardiology and Therapy, Vol 8, Iss 2, Pp 229-237 (2019)
Cardiology and Therapy
Cardiology and Therapy
Introduction This prospective study aimed to determine whether trimetazidine (TMZ) alters the pharmacodynamic (PD) effects of clopidogrel. Methods Patients with stable coronary artery disease (SCAD) (n = 24) who were actively treated with dual antipl
Autor:
B. Shivananda Nayak, Victoria Seebalack, Shalina Singh, Nirvani Siraramsingh, Shawn Seepersad, Kameel Mungrue, Crystal Skeete, Cadina Samaroo, Justin Sookram, Munish Sharma
Diabetes mellitus globally is expected to double from 175 million in the year 2000 to 353 million in 2030.1 This results in the urgent need for cheap and effective screening and diagnostic methods. Although several are available, fasting plasma gluco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c87c7d20db528747a540fe82f0722b56
https://europepmc.org/articles/PMC3440059/
https://europepmc.org/articles/PMC3440059/